Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Thousand Talents Program and Research Security

China’s Thousand Talents Program, how it became the center of US research-security enforcement, the DOJ’s China Initiative prosecutions (including the Charles Lieber case), and the disclosure rules that replaced it.

The Thousand Talents Program was a Chinese government talent-recruitment initiative that became, from roughly 2018 onward, the central flashpoint in US federal research-security policy. Its history explains why disclosure rules for foreign affiliations, grants applications, and technology-transfer review look the way they do today across NIH, NSF, DOE, and other federal research agencies.

What the Thousand Talents Program Was

China’s Thousand Talents Plan (sometimes rendered Qianren Jihua) was launched in 2008 under the Chinese Communist Party’s Central Organization Department to recruit scientists, engineers, and other high-level experts — both ethnic-Chinese researchers working abroad and, to a lesser extent, non-Chinese specialists — to work in or consult for institutions in China. Recruits typically signed multi-year contracts that could include a salary, living-expense allowances, and a lab start-up package funded by a Chinese university, institute, or company, often layered on top of the recruit’s existing full-time position and funding at a US, European, or other overseas institution.

On its own, that structure is not illegal or inherently improper. International talent recruitment, joint appointments, and visiting-scholar arrangements are ordinary features of global science, and CASRAI’s broader guide to US-China research collaboration covers the full range of legitimate cross-border research activity. What made the Thousand Talents Program specifically a compliance and law-enforcement concern was a recurring pattern: US-based researchers who held simultaneous, compensated affiliations with the program did not disclose them — on federal grant applications, in annual progress reports, or to their home institutions — even though every major US funding agency requires disclosure of other sources of research support, appointments, and in-kind resources as a condition of the award.

Why It Became a US Research-Security Concern

Two distinct concerns converged on the program specifically, rather than on international collaboration generally:

  • Undisclosed foreign affiliations and double-dipping. Federal funders require investigators to disclose all current and pending sources of research support, including foreign appointments and in-kind resources, so agencies can identify duplicate funding of the same work and so institutions can identify conflicts of commitment (how an investigator’s time is actually allocated across employers). Program participants who certified “no other support” while receiving a parallel salary, lab funding, and living expenses from a Chinese institution were making a false statement on a federal document, not merely omitting a minor detail.
  • Intellectual property and technology transfer. Because Thousand Talents contracts frequently required recruits to establish a shadow lab, transfer research materials or techniques, or train students at the Chinese host institution, US government reviewers treated the program as a mechanism through which federally funded research — including in areas like nanotechnology, semiconductors, and other dual-use fields — could be transferred to China outside the review channels export-control law and federal grant terms already require. This is the same underlying concern that governs deemed exports and controlled technical data under the NSPM-33 disclosure framework and export-control regimes like ITAR and the EAR.

The China Initiative and the DOJ Prosecutions (2018–2022)

In November 2018, the US Department of Justice launched the China Initiative, an enforcement program explicitly aimed at countering Chinese economic espionage and, within its academic-sector component, at researchers who concealed Thousand Talents or other foreign-talent-program affiliations from federal funders. Dozens of investigations followed, primarily under federal false-statement and grant-fraud statutes (18 U.S.C. § 1001 and related provisions) rather than under espionage law, since most of the underlying research at issue was unclassified, published science.

The most extensively documented case is that of Charles Lieber, former chair of Harvard University’s Department of Chemistry and Chemical Biology. Per the US Department of Justice’s own charging and sentencing announcements, Lieber was arrested in January 2020 for lying to federal investigators about his role in the Thousand Talents Program and his affiliation with the Wuhan University of Technology, while his Harvard research group had received more than $15 million in Department of Defense and NIH funding between 2008 and 2019. Under a three-year Wuhan University of Technology contract, Lieber was to receive a salary of up to $50,000 per month, living expenses of up to $150,000, and more than $1.5 million to establish a research lab in China. A federal jury convicted him in December 2021 on two counts of making false statements to federal authorities, two counts of filing false tax returns, and two counts of failing to report foreign bank accounts (FBAR violations). In 2023 he was sentenced to time served (two days), two years of supervised release including six months of home confinement, a $50,000 fine, and $33,600 in restitution to the IRS.

The China Initiative’s record beyond that case was considerably more mixed. A number of other prosecutions brought under the initiative were dismissed by DOJ before trial, ended in acquittal, or resulted in convictions on narrower charges than originally filed, and the initiative drew sustained criticism — including from university associations and Asian American advocacy groups — that it chilled legitimate international collaboration and disproportionately targeted researchers of Chinese descent regardless of the strength of the underlying evidence. This page does not attempt to catalog those individual cases, since outcomes varied considerably and many involved contested facts; readers researching a specific matter should consult primary court records and DOJ’s own case announcements rather than secondary summaries.

Why the China Initiative Was Ended

DOJ formally ended the China Initiative in February 2022, folding its function into a broader, non-China-specific strategy for countering nation-state threats to research security. The stated rationale combined the case-outcome concerns above with a policy judgment that a program named after and targeted at one country risked both real and perceived bias in charging decisions, and that research-security risk was better addressed through a uniform, agency-wide disclosure and review framework than through a targeted criminal-enforcement initiative.

What Replaced It: NSPM-33 and the Malign Foreign Talent Recruitment Program Rules

Rather than a criminal-enforcement program, the current federal approach to this risk runs primarily through standardized disclosure. National Security Presidential Memorandum 33 (NSPM-33), issued in January 2021, directs federal research agencies to use common disclosure forms — the standardized biographical sketch and Current and Pending (Other) Support forms now implemented via NIH and NSF’s SciENcv system — and requires research institutions above a federal-funding threshold to stand up institutional research-security programs covering cybersecurity, foreign-travel security, insider-threat awareness, and export-control training.

Separately, the CHIPS and Science Act of 2022 created a specific statutory category, the Malign Foreign Talent Recruitment Program (MFTRP), and prohibits federal grant recipients from participating in one. Unlike the China Initiative, the MFTRP definition is not China-specific: it is a general statutory test (codified at 42 U.S.C. §§ 19231–19237) covering any foreign government talent-recruitment program with characteristics such as required non-disclosure of the participant’s own role, required transfer of intellectual property to the foreign country, or compensation contingent on establishing a lab or program at a foreign entity — the Thousand Talents Program is the paradigmatic example the definition was written around, but it is not the only program that can meet it.

What This Means for Researchers and Institutions Today

The practical compliance obligations that grew out of this history are the ones that now apply regardless of whether a specific talent program is called Thousand Talents or something else:

  • Disclose all foreign appointments, funding, and in-kind support on Current and Pending (Other) Support forms and biographical sketches for every federal application and annual report, including unpaid or honorary titles at foreign institutions if they involve resources, students, or research time.
  • Certify MFTRP non-participation where required — most major federal funders now require an affirmative certification that no key personnel is party to a malign foreign talent recruitment program as a condition of award.
  • Route material transfer and technology-sharing questions through export control and the institution’s sponsored-programs office before entering any foreign consulting, visiting-appointment, or lab-establishment arrangement — particularly in fields covered by the EAR or ITAR.
  • Treat conflict-of-commitment disclosure as separate from, but related to, conflict-of-interest disclosure — a foreign appointment can be fully disclosed and still raise questions about how an investigator’s committed effort on a federally funded project is actually being allocated.

Institutional research-security offices typically pair this with mandatory training — see CASRAI’s guides to NIH research security training requirements and NSF research security training requirements — and with export-control screening under frameworks like ITAR and, for DoD-funded work, CMMC.

Frequently Asked Questions

Is participating in the Thousand Talents Program illegal?

Participation itself was not a US crime. What DOJ prosecuted under the China Initiative was the failure to disclose that participation on federal grant applications and related documents — a false-statement or grant-fraud offense, not a prohibition on the underlying foreign appointment. Since the CHIPS and Science Act, federal grant recipients are separately prohibited from participating in a program that legally qualifies as an MFTRP, which is a distinct, later rule.

Is the China Initiative still active?

No. The US Department of Justice formally ended the China Initiative in February 2022. Research-security enforcement now runs primarily through the disclosure and certification requirements built out under NSPM-33 and the CHIPS and Science Act’s MFTRP provisions, rather than through a dedicated criminal-enforcement initiative targeted at one country.

How is the Malign Foreign Talent Recruitment Program different from the Thousand Talents Program?

Thousand Talents was one specific Chinese government program. MFTRP is a general legal category defined by statute (42 U.S.C. §§ 19231–19237) based on a program’s characteristics — non-disclosure requirements, IP-transfer obligations, foreign-lab-establishment incentives — regardless of which country runs it. Thousand Talents is the program the definition was written around, but any program meeting the statutory test qualifies. See CASRAI’s MFTRP guide for the full certification and disclosure requirements.

Do I need to disclose a Thousand Talents Program affiliation on an NIH or NSF application?

Yes, if it involves funding, resources, or affiliation of any kind, current or pending affiliations with foreign talent programs must be disclosed on Current and Pending (Other) Support documentation, and MFTRP-related certifications must be accurate. Consult your institution’s sponsored-programs or research-security office before submitting, since disclosure requirements and forms have changed multiple times since 2021.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →